Budesonide Oral Suspension Improves Symptomatic, Endoscopic, and Histologic Parameters Compared With Placebo in Patients With Eosinophilic Esophagitis. [electronic resource]
Producer: 20170621Description: 776-786.e5 p. digitalISSN:- 1528-0012
- Administration, Oral
- Adolescent
- Adult
- Anti-Inflammatory Agents -- administration & dosage
- Budesonide -- administration & dosage
- Cell Count
- Child
- Double-Blind Method
- Eosinophilic Esophagitis -- diagnostic imaging
- Eosinophils
- Esophagoscopy
- Female
- Humans
- Male
- Severity of Illness Index
- Suspensions
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.